OssDsign AB

OSSD

SE0012570448

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm 12:00:00 2026-08-14 EDT			5-day change	1st Jan Change
4.100 ^SEK	-6.71%		-0.85%	-63.84%

06-25	Ossdsign Appoints Adam McCollister as New Head of Sales	FW
06-10	OssDsign AB Elects Per Aniansson as Board Member and Chairman	CI

OssDsign – Q3 Presentation 2025

Published on 11/04/2025 at 08:57 am EST

Finwire - Translated by Marketscreener - See original

Add MarketScreener to your sources

OSSDSIGN AB

-6.71%

CEO Morten Henneveld and CFO Anders Svensson present the quarterly report for the third quarter of 2025 and answer questions.

Link to the broadcast: https://www.youtube.com/watch?v=4O_p_xpbz3o

Add MarketScreener to your sources

Latest news about OssDsign AB

06-25	Ossdsign Appoints Adam McCollister as New Head of Sales	FW
06-10	OssDsign AB Elects Per Aniansson as Board Member and Chairman	CI
06-09	Calendar: Tuesday, June 9	FW
06-08	Calendar Tuesday June 9	FW
06-03	Ossdsign announces publication of preclinical study in peer-reviewed scientific journal	FW
06-03	Ossdsign raises proposed board remuneration ahead of AGM	FW
05-22	Adrigo Small & Midcap L/S down 1.8 percent in April – strong reports from Dometic and Bonesupport	FW
05-06	DNB Carnegie lowers fair value for Ossdsign following quarterly report	FW
05-06	Calendar Wednesday May 6	FW
05-05	OssDsign AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-05	OssDsign AB, Q1 2026 Earnings Call, May 05, 2026
05-05	Ossdsign's final figures align with preliminary results	FW
04-13	Affärsvärlden sees opportunity in Ossdsign following profit warning	FW
04-10	Ossdsign Catalyst Q1 2026 sales down 3.6% USD	RE
04-10	OssDsign flags lower sales and earnings for the first quarter	FW

OssDsign AB, formerly known as Oss-Q AB is a Sweden-based orthopedic medical device company. It aims at developing implantable products that respond to clinical challenges, with focus on bone healing. Its primary focus is skull surgery. The Company uses design solutions, material compositions and manufacturing processes mainly based on proprietary bioceramic technologies. The bioceramics it uses integrate with tissues and support bone ingrowth. OssDsign AB's main product is Craniomosaic, an implant for the repair of skull defects (cranioplasty). Along with it, the Company develops bioceramic implants for facial bone augmentation. The Company's customers include neurosurgeons, craniofacial and maxillofacial surgeons.

Employees

Sector

Medical Equipment, Supplies & Distribution

Calendar

08-18 Earnings release - Q2 2026

More about the company